Trimethadione

In the US, Trimethadione (trimethadione systemic) is a member of the drug class oxazolidinedione anticonvulsants and is used to treat Epilepsy, Seizure Prevention and Seizures.

US matches:

• Trimethadione

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AC02

CAS registry number (Chemical Abstracts Service)

0000127-48-0

Chemical Formula

C6-H9-N-O3

Molecular Weight

143

Therapeutic Category

Antiepileptic agent

Chemical Name

2,4-Oxazolidinedione, 3,5,5-trimethyl-

Foreign Names

• Trimethadionum (Latin)
• Trimethadion (German)
• Triméthadione (French)
• Trimetadiona (Spanish)

Generic Names

• Trimethadione (OS: BAN, JAN)
• Triméthadione (OS: DCF)
• Troxidone (OS: BAN)
• Trimethinum (IS)
• Trimethadion (PH: Ph. Eur. 6)
• Trimethadione (PH: BP 2010, JP XIV, Ph. Int. 4, USP 23, Ph. Eur. 6)
• Trimethadionum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Mino Aleviatin
  Dainippon Sumitomo, Japan



• Tridione
  Abbott, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.